中文
Smart and lightweight medical imaging cloud
establishing a fast, convenient and stable medical imaging intelligent processing platform
Knowing Vision, Knowing Doctor
Focusing on the world's leading computer vision algorithms, in-depth researching on the doctors’ requirement

Product introduction

Products

Intelligent imaging processing platform
Real-time detection of lung tumors and pulmonary nodules, achieving pixel-level segmentation of multi-scale lesions and intelligent quantitative analysis based on the world's leading computer vision algorithms. Accurate elimination of rib shadows on chest X-ray (CXR), making lung markings clearer and achieving higher accuracy of lung diseases diagnosis. Automatic detection and intelligent quantitative analysis of lung diseases in multi-modal imaging.
More
Radiotherapy platform
Fast and automatic delineation of GTV and CTV of nasopharyngeal carcinoma in CT images based on independently developed algorithm, reducing the delineation process to less than 2 minutes that improves the efficiency of doctors significantly. Convenient tools to assist doctors to make more accurate radiotherapy plans for patients based on in-depth research on the doctor's workflow.
More

About us

Introduce

Pvmed
PVmed is a top technology provider with a number of advanced technologies in the field of medical imaging diagnosis of artificial intelligence in the world. It has annotated imaging databases of the highest quality among the peer companies and algorithm accumulation more than 20 years. PVmed has developed several leading products of artificial intelligence, such as world’s first automatic delineation system of nasopharyngeal carcinoma, imaging diagnosis system of lung common diseases. Besides, it has also developed the imaging diagnosis system of breast cancer and liver cancer as well as pathological analysis system of artificial intelligence. PVmed has developed scientific research and industrialization cooperation with a number of top hospitals in China. Moreover, it has established business cooperation with several listed companies. In 2018, it got tens of millions financing of Pre-A round. It is the company with the strongest research and development capabilities and the fastest growth rate in the area of AI medical imaging.
More

News

News

2018/08/27
PVmed’s Nasopharyngeal Carcinoma AI Products Released with Philips IntelliSpace Platform in The First Bethune Hospital of Jilin University
On August 24, 2018, Philips held "The First Product Launch of IntelliSpace Medical Imaging Artificial Intelligence Platform" in the first Bethune hospital of Jilin University, and also supported the “Medical Imaging Big Data and Artificial Intelligence Forum”. Many top experts and industry leaders were invited, including Prof. Changhong Liang (vice chair of the Chinese Medical Association Radiology Branch), Prof. Guangming Lu (vice chair of the Chinese Medical Association Radiology Branch), Prof. Zaiyi Liu (vice chair of the Chinese Medical Association Radiology Branch Youth Committee) and other well-known domestic experts. President of the first Bethune hospital of Jilin University Prof. Shucheng Hua, vice president Prof. Haifeng Wang and director of radiology Prof. Huimao Zhang attended the product launch and academic forum. The participating experts and scholars shared and exchanged innovative ideas, practical achievements and future development of artificial intelligence in imaging equipment, radiology process improvement, image-assisted diagnosis and imaging omics.
Read more
2018/08/01
PVmed debuted at The 9th Chinese National Conference of Nasopharyngeal Cancer and held High-end Closed Seminar
June 29-July 1, 2018, The 9th Chinese National Conference of Nasopharyngeal Cancer was held in Chengdu, Sichuan Province. This conference is hosted by the China Anti-Cancer Association Nasopharyngeal Professional Committee and Sichuan Anti-Cancer Association, and organized by the Cancer Hospital Affiliate to School of Medicine, UESTC·Sichuan Cancer Hospital and the Nasopharyngeal Committee of the Sichuan Anti-Cancer Association. More than 600 experts and scholars from various provinces, municipalities, autonomous regions, Hong Kong, Macao, Taiwan and Europe participated in this academic conference to discuss the hot issues in the diagnosis and treatment of nasopharyngeal carcinoma such as clinical staging, standardized treatment, radio physics and so on. PVmed demonstrated the automatic delineation system for nasopharyngeal carcinoma radiotherapy and other AI technologies and products. During the conference, PVmed held the seminar on “the frontier issues of intelligent optimization of radiotherapy processes”. The seminar invited more than 40 top experts of radiotherapy for nasopharyngeal cancer from major cancer hospitals, including chair of the China Anti-Cancer Association Nasopharyngeal Cancer Committee Prof. Chaosu Hu, next chair from Cancer Hospital Affiliate to School of Medicine, UESTC·Sichuan Cancer Hospital Prof. Jinyi Lang and most of the standing committee members and committee members. President of PVmed Dr. Yao Lu, chief scientific adviser Dr. Chenyang Xu and vice president Dr. Haibin Huang attend the seminar. The frontier issues such as nasopharyngeal cancer radiotherapy process and AI optimization are discussed.
Read more

Our advantage

Advantage

Leading expert team in China
Leading expert team in China
Expert team from international top institutions such as Zhongshan School of Medicine, SYSU, University of Michigan Medical School, Harvard Medical School, Medical School of Illinois State University.
Top technology level in the world
Top technology level in the world
Experience on research and practice of computer-aided diagnosis and medical AI over 20 years. Cooperation with GE on the new generation of mammography system and intelligent imaging diagnosis system. Automatic delineation system of nasopharyngeal carcinoma embedded in Philips ISD platform.
Top technology level in the world
Top hospital cooperation
Cooperation with top hospitals in China such as Sun Yat-sen University Cancer Center, Chinese PLA General Hospital and The First Bethune hospital of Jilin University for years.

Partner

Partners